Literature DB >> 23979134

MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.

Zhihong Yang1, Hiroyuki Tsuchiya, Yuxia Zhang, M Elizabeth Hartnett, Li Wang.   

Abstract

We show for the first time that potent microRNA-433 (miR-433) inhibition of expression of the cAMP response element-binding protein CREB1 represses hepatocellular carcinoma (HCC) cell migration. We identified a miR-433 seed match region in human and mouse CREB1 3'-UTRs. Overexpression of miR-433 markedly decreased human CREB1 3'-UTR reporter activity, and the inhibitory effect of miR-433 was alleviated upon mutation of its binding site. Ectopic expression of miR-433 reduced CREB1 protein levels in a variety of human and mouse cancer cells, including HeLa, Hepa1, Huh7, and HepG2. Human CREB1 protein levels in highly invasive MHCC97H cells were diminished by expression of miR-433 but were induced by miR-433 antagomir (anti-miR-433). The expression of mouse CREB1 protein negatively correlated with miR-433 levels in nuclear receptor Shp(-/-) liver tissues and liver tumors compared with wild-type mice. miR-433 exhibited a significant repression of MHCC97H cell migration, which was reversed by anti-miR-433. Overexpressing miR-433 inhibited focus formation dramatically, demonstrating that miR-433 may exert a tumor suppressor function. Knockdown of CREB1 by siRNAs impeded MHCC97H cell migration and invasion and antagonized the effect of anti-miR-433. Interestingly, CREB1 siRNA decreased MHCC97H cell proliferation, which was not influenced by anti-miR-433. Overexpressing CREB1 decreased the inhibitory activity of miR-433. The CpG islands surrounding miR-433 were hypermethylated, and the DNA methylation agent 5'-aza-2'-deoxycytidine, but not the histone deacetylase inhibitor trichostatin A, drastically stimulated the expression of miR-433 and miR-127 in HCC cells. The latter is clustered with miR-433. The results reveal a critical role of miR-433 in mediating HCC cell migration via CREB1.

Entities:  

Keywords:  Cell Migration; HCC; Liver Cancer; MicroRNA; Post-translational Modification; Translation Regulation

Mesh:

Substances:

Year:  2013        PMID: 23979134      PMCID: PMC3789984          DOI: 10.1074/jbc.M113.502682

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Role of cyclic-AMP responsive element binding (CREB) proteins in cell proliferation in a rat model of hepatocellular carcinoma.

Authors:  Stephen J Kovach; Julie A Price; Carolyn M Shaw; Nicholas G Theodorakis; Iain H McKillop
Journal:  J Cell Physiol       Date:  2006-02       Impact factor: 6.384

2.  Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation.

Authors:  Yuxia Zhang; Ping Xu; Kyungtae Park; Yunhee Choi; David D Moore; Li Wang
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 3.  Signaling routes to CREM and CREB: plasticity in transcriptional activation.

Authors:  D De Cesare; G M Fimia; P Sassone-Corsi
Journal:  Trends Biochem Sci       Date:  1999-07       Impact factor: 13.807

4.  CBP-independent activation of CREM and CREB by the LIM-only protein ACT.

Authors:  G M Fimia; D De Cesare; P Sassone-Corsi
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

5.  Novel polymorphisms of nuclear receptor SHP associated with functional and structural changes.

Authors:  Taofeng Zhou; Yuxia Zhang; Antonio Macchiarulo; Zhihong Yang; Marco Cellanetti; Eliecer Coto; Pingyi Xu; Roberto Pellicciari; Li Wang
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

6.  A pivotal role of cyclic AMP-responsive element binding protein in tumor progression.

Authors:  Rinat Abramovitch; Einat Tavor; Jasmine Jacob-Hirsch; Evelyne Zeira; Ninette Amariglio; Orit Pappo; Gideon Rechavi; Eithan Galun; Alik Honigman
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

Review 7.  CREB--a real culprit in oncogenesis.

Authors:  Yeung-Tung Siu; Dong-Yan Jin
Journal:  FEBS J       Date:  2007-06-12       Impact factor: 5.542

8.  Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.

Authors:  Nan He; Kyungtae Park; Yuxia Zhang; Jiansheng Huang; Shan Lu; Li Wang
Journal:  Gastroenterology       Date:  2008-01-10       Impact factor: 22.682

9.  Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma.

Authors:  Guisheng Song; Li Wang
Journal:  Nucleic Acids Res       Date:  2008-09-06       Impact factor: 16.971

10.  MiR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus.

Authors:  Guisheng Song; Li Wang
Journal:  PLoS One       Date:  2008-10-30       Impact factor: 3.240

View more
  57 in total

1.  H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.

Authors:  Yongfeng Song; Chune Liu; Xia Liu; Jocelyn Trottier; Michele Beaudoin; Li Zhang; Chad Pope; Guangyong Peng; Olivier Barbier; Xiaobo Zhong; Linheng Li; Li Wang
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

3.  A Novel Small Molecule Activator of Nuclear Receptor SHP Inhibits HCC Cell Migration via Suppressing Ccl2.

Authors:  Zhihong Yang; Angela N Koehler; Li Wang
Journal:  Mol Cancer Ther       Date:  2016-08-02       Impact factor: 6.261

4.  Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.

Authors:  Jonathan Choiniere; Jianguo Wu; Li Wang
Journal:  Mol Pharmacol       Date:  2016-12-21       Impact factor: 4.436

5.  miR-433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M.

Authors:  Jianhua Yu; Weiguang Zhang; Baochun Lu; Hongwei Qian; Haijun Tang; Zhiyang Zhu; Xinggui Yuan; Peitu Ren
Journal:  Oncol Lett       Date:  2017-12-28       Impact factor: 2.967

6.  MicroRNA-433 Inhibits the Proliferation and Migration of HUVECs and Neurons by Targeting Hypoxia-Inducible Factor 1 Alpha.

Authors:  Lin Zhang; Yuanxiao Zhang; Xiaohua Zhang; Yan Zhang; Yi Jiang; Xinli Xiao; Jing Tan; Wei Yuan; Yong Liu
Journal:  J Mol Neurosci       Date:  2016-11-04       Impact factor: 3.444

7.  Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients.

Authors:  Tal Shahar; Avital Granit; Daniel Zrihan; Tamar Canello; Hanna Charbit; Ofira Einstein; Uri Rozovski; Sharona Elgavish; Zvi Ram; Tali Siegal; Iris Lavon
Journal:  J Neurooncol       Date:  2016-08-29       Impact factor: 4.130

8.  KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.

Authors:  Yu-Shui Ma; Ting-Miao Wu; Bin Qian; Yu-Shan Liu; Hua Ding; Ming-Ming Fan; Ji-Bin Liu; Fei Yu; Hui-Min Wang; Yi Shi; Li-Peng Gu; Liu Li; Lin-Lin Tian; Pei-Yao Wang; Gao-Ren Wang; Zhi-Jun Wu; Qi-Fei Zou; Chang-Chun Ling; Da Fu
Journal:  J Cell Mol Med       Date:  2021-02-23       Impact factor: 5.310

9.  DCC is expressed in a CD166-positive subpopulation of chondrocytes in human osteoarthritic cartilage and modulates CRE activity.

Authors:  Anja-Katrin Bosserhoff; Simone Hofmeister; Anke Ruedel; Thomas Schubert
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 10.  Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?

Authors:  Swetha Rudraiah; Xi Zhang; Li Wang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.